Advanced Search
Contact | Corporate | Help

Bevacizumab, Cetuximab, and Cisplatin With IMRT (Intensity-Modulated Radiation Therapy) for Patients With Stage III/IV Head and Neck Squamous Cell Carcinoma

Sponsors:
  • Memorial Sloan-Kettering Cancer Center
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Head and Neck Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Other: bevacizumab, cisplatin, cetuximab, radiation therapy
Enrollment:
30

Additional information about NCT00968435.


SourceSolution © 2008-2012